ARCHIVES

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

This article is from The Cancer Letter archive.

Vol. 19 No. 14 | April 2, 1993

Download PDF Visit The Full Archive

Related Articles

New CIDAC RFP Limits Recompetition To Small Business Firms

January 6, 1984

NCI To Study Whether It Gets The Most From Advisors.

March 8, 2002

Abstracts Of Papers From Conference On Adjuvant Therapy

April 22, 1977

Virus Cancer Program Report On Scientific Activities

August 1, 1975

DCT Board Approves New Screening Program, Natural Product Concpets

March 1, 1985

FDA Approvals: Lymphoseek Label Updated to Include Head and Neck SCC

June 27, 2014